Adaptive Biotechnologies Corporation (ADPT) vs Scholar Rock Holding Corporation (SRRK)
A side-by-side comparison of Adaptive Biotechnologies Corporation and Scholar Rock Holding Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADPT
Adaptive Biotechnologies Corporation
$29.84HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
SRRK
Scholar Rock Holding Corporation
$43.40HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — ADPT vs SRRK
growth of $100 · dividends reinvested · last 7yADPT -26.0% (-4.2%/yr)SRRK +189.3% (+16.4%/yr)SRRK compounded faster over this window
ADPT SRRK
ADPT vs SRRK: by the numbers
- •SRRK is the larger company ($5.20B vs $4.78B market cap).
- •Both run net losses; SRRK's is the smaller (0.00% vs -20.73% net margin).
Metrics side by side
Valuation
| Metric | ADPT | SRRK |
|---|---|---|
| P/S ratio | 15.50 | N/A |
| P/B ratio | 33.42 | 20.49 |
Profitability
| Metric | ADPT | SRRK |
|---|---|---|
| Gross margin | 75.44% | 0.00% |
| Operating margin | -20.62% | 0.00% |
| Net margin | -20.73% | 0.00% |
| ROE | -44.68% | -161.00% |
| ROIC | -6.67% | -90.04% |
Growth (annualized)
| Metric | ADPT | SRRK |
|---|---|---|
| Revenue CAGR (5Y) | 18.22% | N/A |
| Total return CAGR (5Y) | -1.77% | 8.20% |
Frequently asked
- How have ADPT and SRRK total returns compared?
- Over the past 5 years, ADPT delivered -1.77% and SRRK delivered 8.20% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Adaptive Biotechnologies ROEScholar Rock ROEAdaptive Biotechnologies operating marginScholar Rock operating marginAdaptive Biotechnologies revenue growthScholar Rock revenue growthAdaptive Biotechnologies free cash flowScholar Rock free cash flow
Adaptive Biotechnologies & Scholar Rock appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.